Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 220 | 250 | 570 | 1,060 | 1,370 |
| Marketable Securities | 1,590 | 1,860 | 1,900 | 0 | 0 |
| Receivables | 40 | 50 | 90 | 110 | 10 |
| Other current assets | 10 | 40 | 10 | 50 | 10 |
| TOTAL | $1,860 | $2,200 | $2,570 | $1,220 | $1,390 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 2,460 | 2,490 | 2,510 | 2,540 | 2,580 |
| TOTAL | $2,460 | $2,490 | $2,510 | $2,540 | $2,580 |
| Total Assets | $4,360 | $4,730 | $5,120 | $3,790 | $3,990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 110 | 130 | 230 | 200 | 200 |
| Other current liabilities | 520 | 560 | 590 | 760 | 680 |
| TOTAL | $640 | $690 | $820 | $960 | $880 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $640 | $690 | $820 | $960 | $880 |
| Shareholders' Equity | |||||
| Common Shares | 5,330 | 5,330 | 5,330 | 4,990 | 4,990 |
| Retained earnings | -142,990 | -142,670 | -142,410 | -142,140 | -141,860 |
| Other shareholders' equity | 0 | -10 | -10 | 0 | 0 |
| TOTAL | $3,720 | $4,030 | $4,290 | $2,830 | $3,100 |
| Total Liabilities And Equity | $4,360 | $4,720 | $5,110 | $3,790 | $3,980 |